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INTRODUCTION: Over the past two decades,
continuous improvements in “omics” technol-
ogies have driven an ever-greater capacity to
define the relationshipsbetweengenetics,molec-
ular pathways, and overall phenotypes. Despite
this progress, the majority of genetic factors
influencing complex traits remain unknown.
This is exemplified by mitochondrial super-
complex assembly, a critical component of the
electron transport chain, which remains poor-
ly characterized. Recent advances inmass spec-
trometry have expanded the scope and reliability
of proteomics and metabolomics measure-
ments. These tools are now capable of iden-
tifying thousands of factors driving diverse
molecular pathways, their mechanisms, and
consequent phenotypes and thus substan-
tially contribute toward the understanding of
complex systems.
RATIONALE: Genome-wide association stud-
ies (GWAS) have revealed many causal loci
associated with specific phenotypes, yet the
identification of such genetic variants has
been generally insufficient to elucidate the
molecular mechanisms linking these genetic
variants with specific phenotypes. Amultitude
of control mechanisms differentially affect
the cellular concentrations of different clas-
ses of biomolecules. Therefore, the identifi-
cation of the causal mechanisms underlying
complex trait variation requires quantitative
and comprehensive measurements of multi-
ple layers of data—principally of transcripts,
proteins, and metabolites and the integra-
tion of the resulting data. Recent technological
developments now support such multiple
layers of measurements with a high degree
of reproducibility across diverse sample or
patient cohorts. In this study, we applied a
multilayered approach to analyze metabolic
phenotypes associated with mitochondrial
metabolism.
RESULTS: We profiled metabolic fitness in
386 individuals from 80 cohorts of the BXD
mouse genetic reference population across two
environmental states. Specifically, this exten-
sive phenotyping program included the analy-
sis of metabolism, mitochondrial function, and
cardiovascular function. To understand the
variation in these phenotypes, we quantified
multiple, detailed layers of systems-scale mea-
surements in the livers of the entire population:
the transcriptome (25,136 transcripts), proteome
(2622 proteins), and metabolome (981 metab-
olites). Together with full genomic coverage of
the BXDs, these layers provide a comprehen-
sive view on overall variances induced by ge-
netics and environment regardingmetabolic
activity and mitochondrial function in the
BXDs. Among the 2600 transcript-protein
pairs identified, 85% of observed quantita-
tive trait loci uniquely influenced either the
transcript or protein level. The transomic inte-
gration of molecular data established multiple
causal links between genotype and phenotype
that could not be characterized by any indi-
vidual data set. Examples include the link be-
tween D2HGDH protein and the metabolite
D-2-hydroxyglutarate, the BCKDHA protein
mapping to the gene Bckdhb, the identifica-
tion of two isoforms of ECI2, and mapping
mitochondrial supercomplex assembly to the
protein COX7A2L. These respective measured
variants in these mitochondrial proteins were
in turn associated with varied complex meta-
bolic phenotypes, such as heart rate, choles-
terol synthesis, and branched-chain amino acid
metabolism. Of note, our transomics approach
clarified the contested role of COX7A2L in
mitochondrial supercomplex formation and
identified and validated Echdc1 and Mmab
as involved in the cholesterol pathway.
CONCLUSION: Overall, these findings indi-
cate that data generated by next-generation
proteomics and metabolomics techniques
have reached a quality and scope to com-
plement transcriptomics, genomics, and phe-
nomics for transomic analyses of complex
traits. Using mitochon-
dria as a case in point, we
show that the integrated
analysis of these systems
providesmore insights into
the emergence of the ob-
served phenotypes than
any layer can by itself, highlighting the com-
plementarity of a multilayered approach. The
increasing implementation of these omics tech-
nologies as complements, rather than as re-
placements, will together move us forward in
the integrative analysis of complex traits.▪
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Model of the transomics analysis. A transomics approach was taken to analyze genetic and
environmental variation in metabolic and mitochondrial phenotypes by measuring five distinct
layers of biology in a diverse population of BXD mice. The combined analysis of all layers
together provides additional information not yielded by any single omics approach.
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Recent improvements in quantitative proteomics approaches, including Sequential Window
Acquisition of all Theoretical Mass Spectra (SWATH-MS), permit reproducible large-scale protein
measurements across diverse cohorts.Together with genomics, transcriptomics, and other
technologies, transomic data sets can be generated that permit detailed analyses across broad
molecular interaction networks. Here, we examine mitochondrial links to liver metabolism
through the genome, transcriptome, proteome, and metabolome of 386 individuals in the BXD
mouse reference population. Several links were validated between genetic variants toward
transcripts, proteins, metabolites, and phenotypes. Among these, sequence variants in Cox7a2l
alter its protein’s activity, which in turn leads to downstream differences in mitochondrial
supercomplex formation.This data set demonstrates that the proteome can now be quantified
comprehensively, serving as a key complement to transcriptomics, genomics, andmetabolomics
—a combination moving us forward in complex trait analysis.
O
ver the past two decades, continuous im-
provements in omics technologies have been
driving an ever-greater capacity for quan-
tifying relationships between genetics, the
biochemical mechanisms of the cell, and
overall phenotypes. Despite this progress, the ma-
jority of genetic factors determining complex trait
heritability remain unknown (1). Recent advances
inmass spectrometry (MS) (2–4) have expanded
the scope and reliability of proteomic and meta-
bolomic measurements. These developments in
MS are permitting a leap forward in understand-
ing complex biological systems by facilitating the
accurate quantification of thousands of molecu-
lar factors involved in diverse cellular pathways—
and, therefore, their mechanisms and consequent
phenotypes (5). Thus far, the identification of caus-
al genetic variants alone has been generally insuf-
ficient to characterize the underlying molecular
mechanisms of action. Generating such models
also requires quantitativemeasurements of addi-
tional layers of data, such as transcripts, proteins,
andmetabolites. As amultitude of controlmecha-
nisms differentially affect the cellular concentration
of different classes of biomolecules, multilayered
quantitative measurements on the same individ-
uals can provide synergistic information about
complex systems (6–9) [an approach also dubbed
transomics or high-dimensional biology (10)].
In this study, we generated multilayered data
sets to examinemetabolism across 80 cohorts of
the BXD genetic reference population (GRP). The
BXDs are descended from C57BL/6J (B6) and
DBA/2J (D2) and diverge for ~5million sequence
variants (11), similar to the number of common
variants found withinmany human population
groups (12). This population now consists of
~150 murine recombinant inbred strains with
known variant susceptibility to major metabolic
diseases such as diabetes (13, 14). To date, detailed
biochemical analyses have established validated
links to phenotypes for a few dozen gene variants.
These include links between sweet taste andTas1r3
(15), cadmium toxicity and Slc39a8 (16), and hyper-
activity and Ahr (17). We have previously reported
thatmetabolic phenotypes in the BXDs are highly
variable and that this variability is highly herita-
ble (14). Here, we have analyzed 80 BXD cohorts
(composed of 386 individuals) across a battery of
metabolic tests such as ad libitum running-wheel
access, maximal exercise capacity, and glucose
tolerance. The mice were tested over a 29-week
program where they were exposed to different
environmental conditions of diet: chow diet (CD)
(6% kcal of fat) or high-fat diet (HFD) (60% kcal
of fat). To understand themolecular basis behind
the observed phenotypic variance, we quantified
detailed layers of systems-scale molecular mea-
surements in the livers of the entire population:
the transcriptome (25,136 transcripts), the pro-
teome (2622 proteins), and the metabolome (981
metabolites). Together with full coverage of ge-
netic variants in the BXDs (18), these omics data
sets provide a comprehensive platform for decon-
structing the factors behind variation in clinical
metabolic phenotypes. In all layers of data, trait
variation could be attributed to the causal ge-
netic loci through quantitative trait locus (QTL)
analysis. These layers build on our previous re-
search in this population (19), in which selected
reactionmonitoring (SRM) was used to quanti-
fy 192 proteins and targeted metabolomics ap-
proaches were used to quantify 39metabolites in
the serum and 2metabolites in the liver. This pre-
vious study both shaped our bioinformatics proce-
dures for transomic data sets andprovided positive
controls for the experimental Sequential Window
Acquisitionof all TheoreticalMassSpectra (SWATH-
MS) proteomics and for multilayered pathway
analysis. For example, of the 13 genes with cis-
pQTLs (protein) of the 192 proteins measured by
SRM, 11 were identified in SWATH (all except
AKR7A2andABCB8), and10of these 11 alsomapped
to cis-pQTLs in the independent SWATHdata set.
By applying transomic analyses in these data
sets, we observed that the levels of all four pro-
teins composing the branched-chain ketoacid
dehydrogenase (BCKD) complex in themitochon-
dria are, in the BXDs, tied to genetic variants in a
single gene,Bckdhb. Similarly, a causalmechanistic
linkwas observedbetween theD-2-hydroxyglutarate
dehydrogenase (D2HGDH) protein and the me-
tabolite D-2-hydroxyglutarate (D2HG), which in
turn is linked with similar phenotypes as for
humans with deficiencies in this protein, in-
cluding cardiomyopathy andproblemswithmotor
control (20). Furthermore, the broad proteomics
data set allowed us to identify two isoforms of
the protein ECI2 that were not predicted by eQTL
(expressed transcript) analysis. We examined sev-
eral broad pathways in energy metabolism using
a transomics approach, including lipid storage/
transport, cholesterol synthesis, and the electron
transport chain (ETC), all of which exhibited high
levels of genetic variation at the transcript, pro-
tein, and metabolite levels. This analysis high-
lighted COX7A2L from the ETC—the only one of
67 quantified proteins in the ETC with consistent
cis-pQTLs. Further experiments showed that this
variation in protein leads to strikingly differ-
ential formation of ETC supercomplexes (SCs).
In all cases, the integrated analysis of multiple
omics layers provided more insight into mecha-
nistic networks than could be gleaned from any
layer by itself, highlighting the complementarity
of a multilayered approach.
High-dimensional reconstruction of
complex metabolic traits
To identify new genetic relationships and molec-
ular mechanisms influencing metabolism in the
BXDs, we designed an analytical pipeline to mea-
sure and combinequantitative data from five omics
layers across variable environmental states: ge-
nomics, transcriptomics, proteomics, metabolomics,
and phenomics (Fig. 1A). The 29-week pheno-
typing program includes body weight, indirect
calorimetry, voluntary exercise, maximal oxygen
consumption (VO2max), an oral glucose tolerance
test, and spontaneous activity (Fig. 1B). All traits
vary significantly due to genetic, environmental,
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and/or gene-by-environment (G×E) factors, in-
cluding key traits such as body weight (Fig. 1C)
and glucose response during an oral glucose
tolerance test (Fig. 1D). At the end of the pro-
gram, liver samples were used for multilayered
omics analyses to serve as the platform for deter-
mining the providence and mechanism of metab-
olic variants across the population. Together,
these data support approaches driven by prior
knowledge—e.g., examining the relationships be-
tween known transcriptional and proteomic gene
networkswith relatedphenotypes—aswell as data-
driven approaches—e.g., the denovo identification
of genes that are involved in regulation of meta-
bolic phenotypes.
Before delving into multilayered data sets for
the analysis of complex molecular networks, we
assessed the quality and significance of each omics
layer individually. For phenotypes, heritability
was calculated for all traits within dietary groups
(green and black bars, Fig. 1E), then across all
cohorts combined (red bars). The known environ-
mental factor, diet, furthermore allowed us to cal-
culate the independent environmental effect (blue)
and the strain-dependent G×E influence (yellow).
As expected, HFD feeding strikingly worsens pa-
rameters of metabolic health in most strains, par-
ticularly for traits such as body weight, glucose
response, and running capacity (Fig. 1F). How-
ever, we observed a tremendous range in HFD re-
sponse among BXD strains: The body weight in
some strains is unchanged (e.g., BXD68), whereas
others nearly double in size (BXD44) (Fig. 1C).Next,
we examined the transcriptome data (Affymetrix
MouseGene 1.0 STmicroarrays), inwhich 25,099
annotated probe sets were quantified. Of these,
21,970 were designated as protein coding, with
the unaligned transcripts corresponding to non-
coding genes such as open reading frames and
putative Riken cDNAs or genes that only have
unreviewed UniProt identifiers. When transcript
levels were compared across diets, many of those
most stronglymodulated conform to expectations
from the literature—e.g., Fosl1 is down-regulated
inHFD (21) andPparg is up-regulated inHFD (22)
(Fig. 1G)—although the cause of variation in other
top genes is less clear (e.g., Thnsl1). Likewise for
metabolites; some were observed to be strongly
affected by dietary and genetic factors in both diets
[e.g., farnesyl pyrophosphate (FPP)], and others
fluctuated in only onediet (e.g., allyl isothiocyanate)
aad0189-2 10 JUNE 2016 • VOL 352 ISSUE 6291 sciencemag.org SCIENCE
Fig. 1. Overview and validation of omics layers. (A) General model of the
multilayered approach. Arrows indicate causality between metabolic layers.
HFD should not modify DNA, although other environmental factors can (i.e.,
mutagens). (B) Phenotyping pipeline for all individuals. (See the methods
section for details on each experiment.) (C) Body weight in two strains of
BXD for both diets over the full phenotyping experiment. (D) Area under the
curve (AUC) of glucose excursion during a 3-hour oral glucose tolerance test
for all cohorts. Bars represent mean ±SEM. (E) Heritability for several pheno-
types, calculated byone-way (CD/HFD) or two-way (Mixed) analysis of variance.
Some traits are affected by diet (weight and fasted glucose), others are not
(heart rate and body temperature), and G×E contributions vary. (F) Volcano
plot of diet effect on clinical phenotypes. (G) Volcano plot of diet effect on all
transcripts. (H) Dot plot showing two example hepatic metabolites affected
by diet. (I) An enriched Spearman correlation transcript network using the
cholesterol biosynthesis and SREBF targets gene set. Edges indicate P ≤
0.001. All correlations are positive. (J) Error in SWATH measurements due
to different factors: technical (median CV = 6.5%), biological (CV = 17.0%),
across strain (within diet) (CV = 29.6% HFD, 31.4% CD), and across all mea-
surements (CV = 30.8%). Reported P values between diets (panels C–D, F–H)
are all for Welch’s t-test.
RESEARCH | RESEARCH ARTICLE
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(Fig. 1H). Network analysis of large and metaboli-
cally relevant gene sets in these omics layers, such
as cholesterol biosynthesis (Fig. 1I), showed high
levels of enrichment in transcript covariation
compared with noise, indicating that the vari-
ant transcript levels are functionally linked and
physiologically relevant (described inmore detail
later). We then assessed the data generated by
SWATH-MS proteomics (3). As SWATH-MS is an
emerging technology, we performed several addi-
tional checks, including the technical error, the
biological error within cohort, and the errorswith-
in diet and across all samples (Fig. 1J). Reproduc-
ibility was excellent, with median technical error
being ~8% of overall variation in protein levels.
Similarly, variation within biological replicates
was much lower than variation across the geno-
types or dietary conditions (Fig. 1J).
Next, we examined transcript-protein relation-
ships. Of the 2622 unique proteins quantified in
all cohorts, 2600 aligned to measured transcripts.
Spearman correlation analysis was performed for
all pairs in both diets independently. The data
indicated that 1004 transcript-protein pairs cor-
relate at nominal significance in CD (raw P <
0.05) (Fig. 2A) and 938 in HFD cohorts. Of these,
637 pairs (~25%) correlated at least nominally
significantly in both diets (Fig. 2B, green, purple,
and red points). This moderate—although still
highly significant—correlation between genes’
SCIENCE sciencemag.org 10 JUNE 2016 • VOL 352 ISSUE 6291 aad0189-3
Fig. 2. Multilayer analysis of associations and causality. (A) Histogram of
2600 transcript-protein pair Spearman correlations in CD. r = 0.32 corre-
sponds to a nominal P < 0.05. r = 0.65 corresponds to Bonferroni-corrected
significance. (B) Correlation plot of transcript-peptide Spearman correlation
coefficients in CD against HFD. (C) Transcript-protein correlation prevalence in
CD cohorts, binned by transcript variation. Among the top 10% most variable
transcripts (260 pairs), 56% of pairs correlate, in contrast to only 20%of pairs
in the lowest bin. Nominal significance cutoffs are used, so ~5% of matches in
each bin are false positives. (D) The transcriptPura correlates significantly with
its protein in CD but not in HFD. (E) Malate and fumarate, two adjacent
metabolites in the TCA cycle, correlate strongly. Several other cross-layer
correlations are observed between metabolites and their adjacent enzymes
in major metabolic pathways. (F) Venn diagram and count of all cis- and trans-
eQTLs across diets for the 2600 transcripts with matching protein measure-
ments. (G) Venn diagram and count of all cis- and trans-pQTLs for the same
2600 proteins. (H) Overlap between cis-eQTLs and cis-pQTLs in both diets.
Fifty-nine genes map to cis-QTLs in all four data sets (intersection not shown).
(I) Venn diagram of all mQTLs and cQTLs in both diets. In red for cQTLs:
overlapping cQTLs that are genome-wide significant in one diet (LRS ≥ 18) and
locally significant in the other (LRS ≥ 12).
RESEARCH | RESEARCH ARTICLE
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transcripts and proteins is in line with previous
population studies,which examined smaller num-
bers (hundreds) of such pairs (19, 23). Variation in
any given transcript or protein’s expressionwithin
a single tissue in normal population data sets can
be highly variable. Among the 2600 transcript-
protein pairs, 90% of transcripts vary between
1.4- and4.0-fold across all samples. Themagnitude
of this variance strongly influences cross-layer cor-
relation. When the 2600 paired transcripts are
binned into 10 groups based on expression range
across CD cohorts, the highest bin has 260 tran-
scripts with ≥2.8-fold range, whereas the lowest
bin has 260 transcripts with ≤1.4-fold range. Cor-
respondingly, 56% of transcript-protein pairs cor-
relate at r ≥ |0.32| (raw P ≤ 0.05) in the top bin,
versus only 20% in the lowest bin (Fig. 2C). Fun-
damentally, a protein cannot exist if there is no
corresponding transcript; thus in some sense, 100%
of transcript-protein pairs could be considered
correlated. Conversely, we observe that only ~15
to 20% of transcript-protein pairs are reactive to
small changes in the other’s expression (i.e., the
lower bins) (Fig. 2C).
As with phenotypes and transcripts, G×E effects
were observed in transcript-protein correlations,
such as for the several dozen transcript-protein
pairs whose correlation segregated depending on
diet (Fig. 2B, purple dots). For the 137 most signif-
icant correlations—those that met the Bonferroni-
corrected significance threshold (corresponding
to r = ±0.65) in at least one diet—135 correlated
at least nominally significantly (P < 0.05) in the
other diet with the same directionality. For the
other two, Cyp2b9 and Pura, strong correlation
was observed in one diet and no correlation in the
other (e.g., Fig. 2D). This frequent discrepancy be-
tween variation in transcript and protein levels
indicates that reanalyzing metabolic pathways
using more comprehensive proteomic coverage
can identify unknownbiologicalmechanisms. Last,
we examined the metabolomics layer. Here, me-
tabolite signatures of 979 unique mass-to-charge
ratios (m/z) were measured in 357 liver samples
using a time-of-flight MS approach (24). These
979 features were then aligned to specific chem-
ical signatures using previously assembled ref-
erence libraries (24). Initial data quality checks
were performed by analyzing successive metab-
olites within pathways, such as the tricarboxylic
acid (TCA) cycle and glycolysis. Clear connections
were frequently observed between consecutive
metabolites of a given pathway, such as between
malate and fumarate (Fig. 2E). Althoughmetab-
olites do not fit as neatly into the direct relation-
ships of gene-transcript-protein, themeasurement
quality and the physiological relevance of metab-
olite variationmay be examined through relation-
ships between the transcript and protein levels of
different enzymes with their up- or downstream
metabolites. In this analysis, cross-dimensional cor-
relations between known factors were frequently
observed, including for cholesterol biosynthesis,
glycolysis, and the TCA cycle (25) (Fig. 2E). To-
gether, these validation steps confirm the general
data quality and reliability and the potential of a
multilayered analytical approach.
Metabolic relationships to
multilayered data
We next sought to identify causal genetic mecha-
nisms that determine molecular expression levels
aad0189-4 10 JUNE 2016 • VOL 352 ISSUE 6291 sciencemag.org SCIENCE
Fig. 3. Identifying the QTGs and causal mechanisms driving QTLs. (A) Com-
bined QTL map of Bckdha transcript and protein in both diets. Significant
trans-pQTLs map to Bckdhb (yellow triangle) on chromosome 9, whereas no
cis-QTLs map to Bckdha on chromosome 7 (red triangle). (B) Spearman
correlation matrices of the four subunits of the BCKDC at the transcript or
protein level in both diets. (C) Homeostatic model assessment for insulin
resistance (HOMA-IR) is significantly increased in HFD cohorts compared
with CD (P = 2 × 10–6, Welch’s t test), but no association is seen between
Bckdhb allele and HOMA-IR in either dietary cohort. (D) D2HG maps signi-
ficantly to chromosome 1 in the HFD cohort. (E) This locus contains 56 genes,
of which 16 have a major genetic variants variable, including D2hgdh. (F) Com-
posite eQTL and pQTL map for D2hgdh. The protein maps as a cis-pQTL in
both diets to the same chromosome 1 locus, whereas only the HFD tran-
script levels map to a cis-eQTL. (G) D2hgdh drives one of several pathways
generating a-ketoglutarate. (H) D2HG is positively associated with heart rate
in both diets in a Pearson correlation. (I) Eci2 exhibits no cis-eQTLs, but yields
significant cis-pQTLs in both diets. (J) Peptide sequence analysis of ECI2, with
the nine measured peptides and the single missense mutation highlighted.
(K) ECI2 Western blots show two distinct molecular weight bands depending
on the BXD genotype.
RESEARCH | RESEARCH ARTICLE
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Fig. 4. Network analysis. (A) Spearman correlation network showing mixed
genes involved in fat metabolism at the transcript and protein level, along with
key metabolites and phenotypes. The dashed circle represents the core en-
richedgene set. Edges are significant atP<0.001 for a positive (blue) or negative
(red) correlation. (B) Diet-dependent expression of key genes and metabolites
involved in fat metabolism; P values are for Welch’s t test. (C) A Spearman
correlation network of 74 transcripts taken at random from the list of 2600
genes measured at the transcript and protein level, using the same network
analysis. Edge counts correspond to the level expected from noise. (D) (Left)
Hmgcs1 and Srebf1, as well as other transcripts and proteins in the cholesterol
biosynthesis pathway, are highly variable in the BXDs. (Right) PCA of a set of
eight cholesterol biosynthesis genes shows that their variances are highly
explained by a single factor. (Bottom) Two candidate cholesterol genes,
Mmab and Echdc1, which correlate with PC1 in both diets. (E) In vitro validation
of HMGCS1, along with two proteins not known to be involved in cholesterol
metabolism—MMAB and ECHDC1—which clustered with known cholesterol
genes.MMABand ECHDC1 both respond like HMGCS1 to lipid-deficient serum
and statin treatment or to knockdown of LDLR, SREBF2, or SREBF1/2, sug-
gesting that they are indeed involved in cholesterol metabolism. (F) Unbiased
Spearman correlation matrices of the first PC in CD (bottom left) and HFD
(top right) conditions with other genes turned up many known cholesterol-
regulatory genes (orange) as well as new candidates (green). (G) Transcript
and protein networks for the 73 genes with paired transcript-protein data in
the cytosolic ribosome complex. Both were highly enriched, although with
tighter coregulation at the transcriptional level. Edges represent Spearman
correlations with P < 0.0001.
RESEARCH | RESEARCH ARTICLE
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of any of the omics layers through QTL analysis.
The cohorts in both dietary states were analyzed
for eQTLs, pQTLs,mQTLs (metabolite), and cQTLs
(clinical phenotype). Across all 2600 transcripts
for which we generated associated protein data,
543 genes mapped to 770 significant cis-eQTLs
and 472 genes mapped to 481 distinct trans-eQTLs
(Fig. 2F) (QTLs detected in both diets are con-
sidered twice). Of the 543 genes with cis-eQTLs,
227 mapped consistently across both diets (41%),
whereas trans-eQTLs rarely overlapped (2%overlap
detected, with ~0.2% overlap expected by chance)
(Fig. 2F). At the protein level, 632 distinct genes
mapped to 856 cis-pQTLs, and 382 genes mapped
to 406 distinct trans-pQTLs (Fig. 2G). Across diets,
we observed that 35% of cis-pQTLs mapped in
both diets, similar to the ratio for transcripts. Con-
sistent trans-pQTLs were still quite rare, albeit
more common than for transcripts (~6%). Roughly
4% of examined genesmapped as cis-eQTLs and
cis-pQTLs in at least one diet (103 or 109 versus
2600), whereas of geneswith a cis-QTL of any sort,
roughly 85%were unique to the transcript or pro-
tein level (103 of 826 for CD and 109 of 800 for
HFD were shared cis-QTLs) (Fig. 2H). Fifty-nine
genes (2.2%) mapped to cis-QTLs in both layers
and both diets. For the metabolite layer, 315 sig-
nificantmQTLs (LRS≥ 18) were detected, of which
13 mapped consistently in both dietary states
(~4%). For phenotypes, we calculated 37 signif-
icant cQTLs, of which 2 mapped significantly to
the same locus in both diets: movement activity
[caused by Ahr (17)] and heart rate (causal gene
unknown). To increase the scope of QTLs consist-
ent across diets, one dietary data set may also be
used to identify a hypothesis at system-wide sig-
nificance (LRS ≥ 18), and the other diet may be
used to test the hypothesis at locus-specific sig-
nificance (LRS ≥ 12). In doing so, an additional
7 cQTLs are observed as consistent in both diets
(Fig. 2I, red number).
Solving QTLs: Finding the quantitative
trait gene
For cis-QTLs, the causal factors can be quickly
identified: With few exceptions, they will be driv-
en by variants within the gene itself or imme-
diately adjacent. For trans-QTLs, mQTLs, and
cQTLs, the identification of the causal quanti-
tative trait gene (QTG) is challenging due to the
width of the QTLs. In the BXDs, QTLs calculated
using 40 strains are typically 2 to 8 Mb wide,
with an average of 10 genes per Mb (14). We first
examined the 24 genes with trans-pQTLs that
were observed in both dietary cohorts to search
for QTGs and downstream effects. One of these
24 genes is Bckdha, which encodes the E1 alpha
polypeptide of the BCKD complex. The BCKDHA
protein levels map to a trans-pQTL on chromo-
some 9 in both diets, whereas no such trans-eQTL
is observed for the Bckdha transcript (Fig. 3A).
Strikingly, this locus contains the E1 beta poly-
peptide, Bckdhb, which itself has cis-pQTLs and
cis-eQTLs in the BXDs (19). Bckdha and Bckdhb
encode the E1 subunit of the BCKD complex,
which, together with the E2 (Dbt) and E3 (Dld)
subunits, regulates the breakdown of branched-
chain amino acids (BCAAs). Variants in either E1
subunit can lead to an inborn error ofmetabolism
called type 1 maple syrup urine disease (MSUD)
(26), the biochemical features of which some
strains of the BXDs are known to exhibit (19). No-
tably, the transcript levels of these four genes
coding for the complex components haveno strong
association, whereas the expression levels of the
proteins are strongly coupled (Fig. 3B). That is,
genetic variants inBckdhb are causal for protein
level variation in BCKDHA and BCKDHB, which
in turn correlate strongly positively with dihydro-
lipoamide branched chain transacylase E2 (DBT)
anddihydrolipoamidedehydrogenase (DLD) levels
in both diets: the levels of all four proteins are
linked. Conversely, although Bckdhb gene variants
cause transcriptional changes in Bckdhb mRNA
(a cis-eQTL), there is no effect on BckdhamRNA,
nor any correlation with Dbt or Dld. Although a
significant difference in the BCAA/alanine ratio
across the BXDs has been observed and linked to
the Bckdhb allele (19), we observe no association
with other metabolic hallmarks of MSUD, such
as insulin or glucose levels (Fig. 3C). However, such
a link may only be observed in more exacerbated
states, such as in cohorts fed diets high in BCAAs,
as suggested by prior literature (27). This ex-
ample highlights the importance of examining
protein levels in the diagnosis and elucidation of
other metabolic diseases and underlines the pos-
sibility of using the BXDs as a MSUD model.
Additionally, this finding highlights the possibility
that the expression levels of proteins within mul-
tigene complexesmay bemore tightly coregulated
than are their transcripts (e.g., Fig. 3B).
We then aimed to identify candidate QTGs be-
hind any of the 302 distinctmQTLs using orthog-
onal pQTL data. All 856 genes with cis-pQTLs
were compared against these mQTLs, with the
hypothesis that genes with cis-pQTLs are more
likely to be causal for otherQTLsmapping to their
locus (28). This process highlighted several po-
tential pQTL/mQTL links. In particular, D2HG
maps to a locus on chromosome 1 containing
56 genes (Fig. 3, D and E). Among these 56 genes
is D-2-hydroxyglutarate dehydrogenase (D2hgdh),
which maps consistently to cis-pQTLs (Fig. 3F)
and correlates negatively with the upstream me-
tabolite D2HG (r = –0.37 and r = –0.48 in CD and
HFD, respectively). Although the other 55 genes
in this locus could contribute to thismQTL,D2hgdh
is known to convertD2HGtoa-ketoglutarate in the
mitochondria (29) (Fig. 3G). In humans, variants
in D2HGDH have been linked to severe disease
traits such as cardiomyopathy and motor diffi-
culties (20). In the BXDs, we observe moderate
but consistent connections between D2HG and
cardiovascular phenotypes such as heart rate (Fig.
3H) and exercise capacity (moderate negative cor-
relation), indicating that somemild aspects of the
disease phenotype may manifest in this popula-
tion, even under nonstressed conditions.
The SWATHproteomics analysis is also able to
identify nonsynonymous sequence variants across
the BXDs, which are detected as peptide-specific
cis-pQTLs [cis-peptide(pep)QTLs]. To demonstrate
this, we highlight enoyl-CoA delta isomerase 2
(Eci2), a mitochondrial enzyme involved in fatty
acid oxidation. Nine distinct peptideswere quan-
tified for ECI2, of which one displayed a striking
cis-pepQTL in both diets. Interestingly, there are
no cis-eQTLs for ECI2 at the gene or exon level
(Fig. 3I). Variant analysis revealed anonsynonymous
change (R135Q, rs13464612) adjacent to this pep-
tide that is predicted to abolish the trypsin cleav-
age site (Fig. 3J). Furthermore, this cis-mapping
variant trackswith a small change ECI2migration
in SDS–polyacrylamide gel electrophoresis (SDS-
PAGE) (Fig. 3K), indicating a change in the protein
that is not observed at the transcript level. Notably,
these analyses highlight the ability to detect pu-
tative protein isoforms—an additional source of
molecular variationunderlying complexphenotypes.
High-dimensional metabolic networks
As shown above, large, multilayered quantitative
omics data sets can be used tomap and solveQTLs
at high throughput. Perhaps the more unique
characteristic of more comprehensive measure-
ment techniques, however, is that the resulting
datamay be used tomodel extended pathways or
functional networks with dozens of proteins and
metabolites acting in tandem. To examine this
possibility in the BXDs, we performed ontology
enrichment analysis on 226 KEGG (Kyoto Ency-
clopedia of Genes andGenomes) pathways (30) to
identify which other metabolic pathways are best
covered by the proteomic and metabolomics data
andmaybenefit froma transomic approach.Among
themost enriched pathways are those involved in
fatty acid metabolism and storage, such as the
peroxisome proliferator-activated receptor (PPAR)
pathway. These sets of genes and pathways are
furthermore known to be variable in the BXDs
and lead to overt differences in fatty liver and
metabolic changes in the liver, includingmetabolic
signatures of liver stress such as increased alanine
transaminase (ALAT) and disease phenotypes such
as fatty liver disease (21). Of the 41 genes in this
pathway, 25 were measured at the protein level,
along with a handful of relevant metabolites [e.g.,
FPP, ALAT, and high-density lipoprotein (HDL)].
Interestingly, although the transcripts andproteins
for any single gene did not strikingly correlate
(Fig. 4A), significant enrichment of correlations
between transcripts and proteins was observed in
other parts of the pathway (Fig. 4A, dashed circle),
indicating interactions between these two layers
and between relatedmetabolic pathways. In turn,
the variations in these transcripts and proteins
contributed to proximal metabolic changes [e.g.,
low-density lipoprotein (LDL),HDL, andFPP levels]
and to related global phenotypes such as total fat
and liver mass. This network is also highly re-
sponsive to diet, with clear differences between
CD and HFD cohorts in key genes and metabo-
lites (Fig. 4B). While these findings are expected
(21), they further emphasize the reliability of cross-
layer omics analysis and furthermore provide bet-
ter networks than those expected using random
gene sets (Fig. 4C).
Within the fat metabolism gene set, we ob-
served particularly high levels of variability in key
genes in cholesterol biosynthesis such as Srebf1
aad0189-6 10 JUNE 2016 • VOL 352 ISSUE 6291 sciencemag.org SCIENCE
RESEARCH | RESEARCH ARTICLE
 
o
n
 Ju
ne
 1
0,
 2
01
6
ht
tp
://
sc
ie
nc
e.
sc
ie
nc
em
ag
.o
rg
/
D
ow
nl
oa
de
d 
fro
m
 
SCIENCE sciencemag.org 10 JUNE 2016 • VOL 352 ISSUE 6291 aad0189-7
Fig. 5. Variable mitochondrial phenotypes in the BXDs. (A) The oxphos
protein Spearman correlation network is somewhat more tightly coregulated
than the transcript network. In particular, CI proteins cluster more tightly than
CI transcripts (black nodes). (B) Circos plot of 67 ETC genes. Green bar ring:
effect of diet, relative change between medians. Light green: transcript; dark
green: protein. Purple bar ring: correlation between transcript and protein in CD
(light purple) or HFD (dark purple). Red bar ring: LRSof peak pQTLs in CD (light
red) andHFD (dark red). Blue bar ring: LRSof peakeQTLs in CD (light blue) and
HFD (dark blue). Inside: drawing of significant cis-QTLs (LRS ≥ 12). Significant
trans-QTLs (LRS ≥ 18) are not drawn. (C) Diet-consistent cis-pQTLs were ob-
served only for COX7A2L,which does notmap to significant cis-eQTLs. (D) (Top)
The Cox7a2l transcript is affected by diet, whereas both transcript and protein
are highly variable across genotype. (Bottom) Expression is consistent across
diets within the transcript and protein level, despite the presence of dietary
effect in mRNA and its absence in protein. (E) BN-PAGE for four strains with
three biological replicates. Individual complexes are labeled. Several distinct
upper SC bands are observed, labeled initially as 1 through 6. (F) Upper SCs
for all CD cohorts (several independent gels are aligned and spliced together).
SCs were quantified in binary fashion by presence (+1) or absence (0) of a
particular band.
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andHmgcs1 (Fig. 4D, left). Furthermore, key Srebf
target genes, including Hmgcr, Pcsk9, Insig1, and
Fasn, all clustered tightly in principal components
analysis (PCA), with the first principal component
of eight core genes explaining 70 and 81% of the
total variation in CD and HFD, respectively (Fig.
4D, right). Correlation analyses of the first princi-
pal components across the transcriptome and pro-
teome data sets yielded several hits that correlate
strongly and independently in both CD andHFD
cohorts. These genes included several not known
to be involved in cholesterol biosynthesis, such
asMmab and Echdc1 (Fig. 4D, bottom), as well as
a number of genes involved in cholesterol that
were not included in input, such as Fdps,Mvd,
and Dhcr7. We selected two hits, Mmab and
Echdc1, which are notwell reported in cholesterol
literature, for in vitro validation. In HepG2 and
Huh7 cell lines, we examined the effect of cells in
lipoprotein-deficient serum (LPDS) treated with
statins and the effect of Ldlr, Srebf2, or Srebf1/2
small interfering RNA (siRNA) knockdown—
conditions that modulate different aspects of the
cholesterol biosynthesis pathway (31–33). We ob-
served thatMMAB and ECHDC1 proteins aremod-
ulated strongly by LPDS + statin treatment and
behave similarly (although not identically) to
HMGCS1, an established Srebp2 target protein
and a key regulatory gene in cholesterol synthesis.
Similar genome-wide analyses indicated addi-
tional candidate cholesterol-related genes, such
as Aqp8, 0610007P14Rik, and Gpam (Fig. 4F).
Some of these genes have been identified in pre-
vious cholesterol genome-wide association studies,
such as forMmabwith bloodHDL levels (34, 35),
whereas other candidates are likely involved in
tangential pathways (e.g., Acot1 and Acot2 are
involved in lipid metabolism).
We next examined gene sets that form large
and cohesive protein structures, such as the ribo-
some. Pairwise covariance analysis of transcripts
coding for ribosomal proteins have previously
been shown to form a tightly connected network
(36). To extend this analysis to the protein level,
we systematically generated Pearson correlation
networks for the 73 genes in the ribosome family
that were measured at both the transcript and
protein level in all samples. As for the transcripts,
the proteins clustered into enriched correlation
networks (Fig. 4G). That the ribosomal genes are
coregulated is expected, but it illustrates that the
data are reliable enough to reveal components of
functional modules and thus to support systems
analyses.
Following these proofs of concept, we deter-
minedwhichmetabolic pathwaysweremost com-
prehensively covered in themultilayered data sets
and triaged them for further analysis, with partic-
ular focus on mitochondria-related sets. Among
the groups with the most complete protein cov-
eragewas the oxidative phosphorylation gene set
(oxphos, hsa00190). This gene set is defined by
133 genes, of which 70 were quantified at the pro-
tein level. Of these, 67 were also quantified at the
transcript level—all except the mitochondrial-
encoded ND4, ND5, and ATP8. We performed
network analyses on these data and observed
highly significant positive correlation networks
(Fig. 5A), with the protein network somewhat
more enriched than the transcript network. This
layer-specific difference in network structure is
perhaps logical, given that the proteins are bound
together in stoichiometry in their functional com-
plexes, whereas the equivalent transcripts are not.
The oxphos network was not strongly affected by
diet, with only four proteins and 16 transcripts
being variable at the permissive cutoff ofP< 0.01.
(Zeroproteins and four transcripts—Ndufb5,Cox7a2,
Atp5b, andNdufa7—are significantly influenced at
adjusted P < 0.05.) Furthermore, observed dietary
differences at the transcript level did not reliably
indicate any similar change in protein levels (Fig.
5B, outermost green bands.)
Consequences of oxphos variation
Given the relatively small effect of diet on tran-
script and protein levels, surprisingly few QTLs
were observed consistently across diet: only six
transcripts and one protein (Fig. 5B). For the only
such protein, COX7A2L, no corresponding cis-
eQTLs were observed (Fig. 5C). Interestingly, the
Cox7a2l transcript exhibited significantly differ-
ent expression in response to diet, whereas the
protein levels were unaffected (Fig. 5D, top). The
transcript and protein levels were highly corre-
lated across dietary cohorts, suggesting a strong
genetic influence on both Cox7a2l and COX7A2L
levels, independent of the observed dietary influ-
ence on the transcript (Fig. 5D, bottom). Because
mitochondrial transcript and protein networks
are highly variable and coregulated in the BXDs
(Fig. 5A), we hypothesized that these may be as-
sociated with clear differences in mitochondrial
structures and phenotypes. To broadly test this
idea, we performed blue native (BN)–PAGE analy-
sis on isolatedmitochondria from three biological
replicates across all strains, using the same liver
samples as before. Mitochondrial complex levels
and formations varied across the BXDs (Fig. 5E),
with particularly striking differences in SC for-
mations (Fig. 5F, all strains). The differences in
SC patterns across strains, and the consistency
within strains, indicate that complex and multi-
factorial genetic interactions are driving the mito-
chondrial effects, at least in part by determining
the modularity of supermolecular functional units.
To uncover these factors, we assigned the SC bands
as quantitative traits, with all bands quantified
as “on” (+1) or “off” (0). These traits were then
mapped for QTLs. For bands 4 and 5, the data
indicated that they are driven by a locus on chro-
mosome 17 (Fig. 6A), containing 35 genes. Notab-
ly, this region includes Cox7a2l, and overlaps
with its cis-pQTLs (Fig. 5C). Cox7a2l has been re-
cently indicated as causal for certain types of SC
formation between different inbredmouse lines
(37), although this effect has been debated (38).
We thus sought to examine how this locus can
affect specific SC formation andwhether Cox7a2l
is indeed causal.
In mammals, SCs are formed by different
stoichiometric combinations of three of the five
individual complexes in the electron transport
chain—complexes I, III, and IV—although it is
poorly understood how they are formed or how
different complexes influence overall mitochon-
drial function (39). To determine the stoichiom-
etry of the observed bands, we performed in-gel
activity assays for complex I (CI), CIV, CI+IV, and
CIII using eight strains: four with the B6 allele of
COX7A2L (e.g., BXD39) and four with the D2
allele (e.g., BXD32) (Fig. 6, B and C).We observed
that SC formations with multiple copies of CIV—
bands 4 (I+III2+IV2) and 5 (I+III2+IV3)—are in-
hibited in strains with B6-type Cox7a2l. Further-
more, a large increase in free/unconjugated CIII
(blue arrow) and CIV (orange arrow) was observed
in those strains with B6-type Cox7a2l, indicating
indeed a lack of the assembly of these complexes
into SCs. This analysis also indicated other varia-
ble SC formations at lower molecular weights,
particularly complex III2+IV1 (dashed red line
and pink arrow, Fig. 6B). Western blot analysis
for COX7A2L shows its presence in SCbands 4 and
5 in D2-type strains (along with band III2+IV1;
this complex was “hidden” under CV in the total
BN-PAGE) and its complete absence in B6-type
strains (Fig. 6C). This effect of COX7A2L on SC
formation is noted broadly across strainswith B6
or D2 alleles of the gene (e.g., Fig. 5F). However,
the variant COX7A2L isoform does not seem to in-
fluence the formation of SC bands 2 (I+III2) or 3
(I+III2+IV1).
We next examined the possibility that the
Cox7a2l may not be the driving factor for SC var-
iation in the BXDs and that the nearby leucine-
rich pentatricopeptide (PPR) motif–containing
gene (Lrpprc)may be causal (38). Lrpprc is 1.2Mb
downstream from Cox7a2l, and four BXD strains
examined have recombinations between this in-
terval: BXD56 has the D2 allele of Cox7a2l and
the B6 allele of Lrpprc, whereas BXD44, BXD49,
and BXD99 have the opposite. For these strains,
SC bands 4 and 5 are absent in BXD44, 49, and
99 and present in BXD56 (Fig. 5F), as expected
if Cox7a2l is causal. Furthermore, neither the
transcript nor protein measurements of Lrpprc
yield QTLs in the BXD livers. This finding does
not preclude the possibility that LRPPRC is in-
volved in SC formation. However, it is not the
causal gene for the variable SC patterns observed
in the BXDs. To further investigate the effects of
COX7A2L on SC formation, we extracted mito-
chondria from the hearts of the same individuals
as the liver. Again, SC patterns were strikingly dif-
ferent depending on genotype (Fig. 6D), yet the
SC bands representing III2+IV1, I+III2+IV2, and
I+III2+IV3 are present in the hearts of strains
with the B6 isoform of Cox7a2l, albeit at dimin-
ished levels comparedwith their D2-type counter-
parts. Taken together, these data provide substantial
evidence to show that COX7A2L is involved in the
formation ofmany CIV-containing SC formations,
yet that its influence varies between tissues. Addi-
tionally, these data provide a conceptual advance-
ment in the current knowledge of SC formations
in B6 by showing that I+III2+IV1 is in fact present
[previously reported as absent (37)] and that var-
iants in COX7A2L are causal for many of the dif-
ferences between B6 and other common inbred
strains, particularly D2.
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Discussion
We have examined genetically and environmen-
tally variant cohorts of the murine BXD GRP to
determine how changes in the genome and envi-
ronment interact to influence cellular processes
and overall variation in complexmetabolic traits.
To model the molecular factors underlying pheno-
typic differences across the BXD population, we
have applied an in-depth, multilayered approach
including genetic, transcriptomic, proteomic, and
metabolomic measurements. Systems-level tech-
nologies now permit the multilayered measure-
ments of thousands of molecules associated with
many physiological processes, at high throughput
and with a high degree of quantitative accuracy
and reproducibility. We show the first application
of SWATH-MS in a diverse mammalian popula-
tion by quantifying 2622 proteins measured in all
80 cohorts. As in earlier smaller-scale studies (40),
genes’ transcript levels are only moderate predic-
tors for the protein levels. The predictive value
depends strongly on how variable the transcript
(or protein) is. Studies that induce massive tran-
scriptional changes with gain- or loss-of-function
techniques can rely on the fact that the resulting
mRNA change will almost invariably be reflected
in the corresponding protein’s level. In contrast,
it cannot be assumed that relatively subtle expres-
sion changes in a particular transcript will mani-
fest at its protein level. This latter situation is
particularly critical for in vivo population studies,
where the top leads identified throughmicroarray
or RNA sequencing (RNA-seq) analyses frequent-
ly have far more modest differences than findings
from in vitro studies. Likewise, genetic variants
driving differential transcript expression (e.g., cis-
eQTLs) are furthermore only infrequently mir-
rored at the protein level (e.g., matched cis-pQTLs)
andviceversa.Measurementofbothtranscriptomics
and proteomics in tandem appears essential be-
cause each measurement level unveils different as-
pectsof thecellular stateandregulatorymechanisms.
This greater scope of data analysis allows the
identification of hundreds of causal genetic factors
that regulate individual transcript and protein
levels (i.e., QTLs), as well as for metabolites and
phenotypes. This protein analysis allowed novel
identification of variants of ECI2 not predicted
SCIENCE sciencemag.org 10 JUNE 2016 • VOL 352 ISSUE 6291 aad0189-9
Fig. 6. Tissue variance in SC formation. (A) SC bands 4 and 5 mapped sig-
nificantly as cQTLs to a locus on chromosome 17. (B) In-gel activity assays were
performed in the liver tissues to determine SC’s composition and relation to
COX7A2L. Bands 2 to 5 could be identified confidently as CI + CIII2 + variable
numbers of CIV (0 to 3). (C) In-gel activity assays from livers of six additional
BXD strains—three with the B6 allele of Cox7a2l (BXD73, BXD80, and BXD100)
and threewith theD2 allele (BXD43, BXD61, andBXD96).COX7A2L is present in
bands 4 and 5 for strains with the D2 allele. (D) In-gel activity assays fromhearts
of the same individuals as above. COX7A2L is absent in bands 4 and 5 and
III2+IV1 in strainswith theB6allele andpresent in strainswith theD2allele.Unlike
liver, bands 4 and 5 are observed in all strains, albeit at lower levels in strainswith
the B6 allele of Cox7a2l, indicating tissue-specific differences in SC formation.
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by genome or transcript data, as well as further
delineation of variants affecting the expression
of the four proteins in the BCKDC—effects not
visible at the transcript level—which lead to a
mild form of MSUD in the BXDs. In another, we
could readily identify the causal factors driving
variance in the metabolite D2HG to the protein
D2HGDH.Moreover, however, the increased scope
of these data facilitates the modeling and analysis
of entire pathways. The PPAR and cholesterol bio-
synthesis pathways are highly variable in the BXDs
due to both genetic and environmental factors
and are known to influence the development of
metabolic diseases, including fatty liver. Further-
more, we were able to use network analysis to
identify Mmab and Echdc1 as likely cholesterol-
related genes, which we confirmed through in
vitro analysis. For the oxphos gene network, the
BXDs display strong levels of variation in both
gene expression and the overall mitochondrial
assembly of complexes in the ETC. Using the pro-
teomic data, we identified COX7A2L as causal of
major variants in SC organization—particularly, a
lack of three specific SC bands (III2+IV2, I+III2+IV2,
and I+III2+IV3)—and a consequent increase of
the unconjugated levels of complexes IV1, III2, and
IV2. However, the mechanism of assembly appears
strongly tissue dependent: These SCs can be formed
in the heart, even in the absence of COX7A2L.
Notably, the patterns of mitochondrial complexes
are consistent across biological replicates, indicat-
ing that the many differences across strains and
tissue are due primarily to differential regulation
of mitochondria by the nuclear genome. In each
of these pathways, the proteomic and metabolo-
mic data extend gene-phenotype links that were
previously identified at the transcript level but
that were incomplete. To move forward in the
analysis ofmitochondria and associated disorders,
it is hence necessary to analyze the protein levels
of all regulators, as well as genetic, environment,
and tissue-specific variants. Such implementations
of new omics layers will not supersede the now-
standard genomic and transcriptomic data sets.
Rather, a combined transomic approach can fill
in blind spots and assist in definingmore detailed
metabolic pathways.
Methods
Population handling
BXD strains were sourced from the University of
Tennessee Health Science Center (Memphis, TN,
USA) and bred at theÉcole Polytechnique Fédérale
de Lausanne (EPFL) animal facility for more
than two generations before incorporation into
the study. We examined 80 cohorts of the BXD
population from41 strains—41 onCD, 39 onHFD—
with male mice from each strain separated into
two groups of about five mice for each diet (two
strains on HFDwere lost before tissue collection).
We started with 201 CD and 185 HFDmice, and a
total of 183 CD and 168 HFDmice survived until
theywere killed at 29weeks of age, with all cohorts
having three ormore individuals surviving to the
end except BXD56 HFD, which had two. Strains
were entered into the phenotyping program ran-
domly andhadstaggeredentry, typically by2weeks.
Most strains entered with both dietary cohorts
at the same time, with the exception of BXD50,
68, 69, 71, 84, 85, 89, 95, 96, and 101, where CD
cohorts entered before HFD cohorts. All cohorts
consisted of littermates. HFD feeding started at 8
weeks of age. Cohorts were communally housed
by strain and diet frombirth until 23weeks of age
andwere then individually housed until they were
killed at 29 weeks of age. CD is Harlan 2018 (6%
kCal of fat, 20% kCal of protein, and 74% kCal of
carbohydrates), and HFD is Harlan 06414 (60%
kCal of fat, 20% kCal of protein, and 20% kCal of
carbohydrates). All mice were housed under
12 hours of light alternatedwith 12 hours of dark,
with ad libitum access to food and water at all
times, except before they were killed, when mice
were fasted overnight. All mice were housed in
isolator cages with individual air filtration, ex-
cept during the activity wheel test (10 days)when
mice were in open-air cages in a room reserved
for that test, after which, mice were returned to
the filtered isolator cages. Body weight was mea-
sured weekly from 8 weeks of age until killing.
Killing took place from9:00 a.m. until 10:30 a.m.,
with isoflurane anesthesia followed by a complete
blood draw (~1 mL) from the vena cava, followed
by perfusion with phosphate-buffered saline. Half
of the blood was placed into lithium-heparin
(LiHep)–coated tubes and the other half in EDTA-
coated tubes; then both were shaken and stored
on ice, followed immediately by collection of the
liver. The LiHep blood taken for plasma analysis
was also centrifuged at 4500 revolutions perminute
(rpm) for 10 min at 4°C before being flash-frozen
in liquid nitrogen. Whole blood taken for cellular
analysis was processed immediately after the kill-
ing (i.e., after ~1 to 2 hours on ice). Gallbladders
were removed, and the livers were cut into small
pieces before freezing in liquid nitrogen until
preparation into mRNA, protein, or metabolite
samples. Liver and blood serumwere then stored
at –80°C until analysis. All research was approved
by the Swiss cantonal veterinary authorities of
Vaud under licenses 2257 and 2257.1.
Phenotyping experiments
A visual summary of the phenotyping program
is also included in Fig. 1B. At 16 weeks of age,
after 8 weeks of dietary treatment, the cohorts
underwent their first phenotyping test: 48 hours
of respiration measurements in individual metabo-
lic cages (Oxymax/CLAMS, Columbus Instruments).
The first 24 hours were considered adaptation,
and the second 24 hours were used for data anal-
ysis, including analysis of movement, the volume
of oxygen inhaled, the volume of carbon dioxide
exhaled, and derived parameters of these two,
such as the respiratory exchange ratio (RER).
One week later, all cohorts underwent an oral
glucose tolerance test. Mice were fasted over-
night before the test, and fasted glucose was
tested with a glucometer at the tail vein. All in-
dividuals were then weighed and given an oral
gavage of 20% glucose solution at 10 mL per kg
of weight. Glucometer strips were used at 15,
30, 45, 60, 90, 120, 150, and 180 min after the
gavage to examine glucose response over time.
Blood was also collected at 0 (pregavage), 15, and
30 min to examine insulin levels. Two weeks later,
at 19 weeks of age, we performed a noninvasive
blood pressure measurement using a tail-cuff
system (BP-2000 Blood Pressure Analysis Sys-
tem, Series II, Visitech Systems) over 4 days. The
first 2 days were considered as adaptation to
the apparatus, and the second 2 days were used
for data analysis, and all measurements (systolic
blood pressure, diastolic blood pressure, and heart
rate) were averaged across both days. Outliers on
a per-measurement basis were removed, but out-
lier mice were retained. Twoweeks later, at 21 weeks
of age, we performed a cold response test. The
basal body temperatures of mice were examined
rectally, after which mice were placed individu-
ally in prechilled cages in a room at 4°C. The
cages were the standard housing cages but with
only simple woodchip bedding, without supple-
ment (e.g., tissue paper). Body temperature was
checked every hour for 6 hours, after which the
mice were returned to their normal housing cage.
Two weeks later, at 23 weeks of age, the mice
were placed individually in regular housing
cages for basal activity recording. The housing
cages were then placed in laser detection grids
developed by TSE Systems (Bad Homburg, Ger-
many). Within the cages, woodchip bedding was
retained, but tissue bedding was removed (as it
interferes with the laser detection). Food and
water were as normal throughout the standard
housing, both of which require rearing to reach.
The detection grid has two layers: one for de-
tecting X-Y movement (“ambulation”) the other
for Z movement (“rearing”). Both measurements
are technically independent, although the meas-
urements of movement are strongly correlated
(r ~ 0.70). Mice were housed individually for the
48-hour experiment starting at about 10 a.m.,
with the night cycles (7 p.m. to 7 a.m., with 30 min
of both dawn and dusk) used for movement cal-
culations. We have recently published more inter-
pretation and examination of the results from
this experiment (17). After this 2-day experiment,
all mice performed a VO2max treadmill experi-
ment using the Metabolic Modular Treadmill
(Columbus Instruments). For the first 15 min
in the machine for each individual, the tread-
mill was off while basal respiratory parameters
were calculated. The last 2 minutes of data before
the treadmill turned on are considered basal lev-
els (most mice spend the first few minutes ex-
ploring the device). The treadmill then started
at a pace of 4.8 m per minute (m/min), followed
by a gradual increase over 60 s to 9 m/min, then
4 min at that pace before increasing to 12 m/min
over 60 s, then four min at that pace before in-
creasing to 15 m/min over 60 s, then 4 min at
that pace, then the speed increased continu-
ously by 0.015 m per second (or +0.9 m/min)
thereafter until the end of the experiment at
63.5 min, 1354.5 m, or when the mouse is ex-
hausted. CD cohorts ran against a 10° incline,
whereas HFD cohorts were set at 0°. For this
test, no mice reached the maximum distance re-
corded by the machine—all were taken out when
exhausted. The distance, maximum VO2, and
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maximum RER were recorded. Maximums must
be consistent acrossmultiplemeasurements, and
not single-measurement spikes, which were re-
moved. Immediately after the treadmill experi-
ment, mice were placed in individual open-air
cages with ad libitum access to activity running
wheels (Bioseb BIO-ACTIVW-M, Vitrolles, France).
The final 24 hours of activity wheel access were
recorded for all strains. For certain strains, all
10 days of activity wheel usage was recorded
(depending on the availability of the recording
system). After the 10th day, at ~25 weeks of age,
mice underwent an identical treadmill experi-
ment to that described above at 23 weeks of age.
At this point, with the 10 days of voluntary train-
ing, three mice “completed” the experiment—two
DBA/2Js onHFD and one BXD81 on CD. As before,
the test was stopped for all othermice when they
had reached exhaustion (considered as falling off
the treadmill and inability to recover and continue
running). After this experiment, mice were returned
to their standard housing cages—individually—for
4 weeks. Mice were fasted overnight before they
were killed. Details about killing are described in
the previous section. In addition to the bodyweight
measurements taken each week and before each
phenotyping experiment, body composition was
recorded at 16, 23, and 25 weeks of age—before
respiration and the two VO2max experiments. To
doso, eachmousewasplacedbriefly inanEchoMRI
(magnetic resonance imaging) machine (the 3-in-1,
EchoMedical Systems), where lean and fat mass
are recorded, along with total body weight, taking
~1 min per individual. Lean mass is used as a
corrective factor for respiratory calculations from
the Comprehensive Lab Animal Monitoring Sys-
tem (CLAMS). All other tests are normalized to
total body weight in our analyses.
Genomics
The parental lines of C57BL/6J and DBA/2J have
been previously sequenced (13). Earlier genotype
data—~8000 single-nucleotide polymorphisms
(SNPs) per line—have been published previously
(42). We have made use of a newer build of the
genotype, using ~500,000 SNPs per line (unpub-
lished), which helped refine recombination break-
points, such that ~99.99% of the genotype of all
BXD strains could be inferred. Full sequence data
on the parental lines was published separately
(18). The lower density (3806 markers) is available
on GeneNetwork as well: www.GeneNetwork.org/
genotypes/BXD.geno.
BXD sample preparation and analysis
For mRNA, 100-mg pieces of liver tissue were
suspended in TRIzol (Invitrogen) and homoge-
nized with stainless steel beads using a Tissue-
Lyser II (Qiagen) at 30Hz for 2min, followed by
a standard phase separation extraction using chlo-
roform and precipitated by isopropanol. mRNA
concentration was measured for all samples and
then pooled equally for each cohort (i.e., five bio-
logical replicates forBXD103CDbecameonemixed
pool of BXD103 CD). Pooled RNAwas cleaned up
using RNEasy (Qiagen). ThemRNA of all cohorts
was prepared in direct series over a ~2-week
period. Seventy-six of the 77 cohorts had high-
quality mRNA based on RNA integrity numbers
≥ 8.0, indicating that they are suitable for ampli-
fication and subsequent microarray analysis. Arrays
were run for all cohorts in direct series over a
3-weekperiodusing theAffymetrixMouseGene 1.0
ST array at the Molecular Resource Center of Ex-
cellence in the University of Tennessee Health
Science Center. Data were normalized using the
robust multiarray average method (43), then ana-
lyzed in GeneNetwork and R.
For liver protein, the ~100-mg liver sample was
homogenized with 4-mL radioimmune precipita-
tion assay-modified buffer (1%Nonidet P-40, 0.1%
sodium deoxycholate, 150mMNaCl, 1 mMEDTA,
50 mM tris, pH 7.5, protease inhibitors EDTA-
free, 10 mMNaF, 10 mM sodium pyrophosphate,
5 mM 2-glycerophosphate) in a glass-glass tight
Dounce homogenizer (Wheaton Science Products)
at 4°C. After the homogenates were centrifuged
(20,000 g at 4°C for 15min), the supernatant was
collected and kept at 4°C. The pellets were re-
suspended with urea-tris buffer (50 mM tris,
pH 8.1, 75 mM NaCl, 8 M urea, EDTA-free prote-
ase inhibitors, 10 mM NaF, 10 mM sodium pyro-
phosphate, 5mM2-glycerophosphate) and sonicated
for 5min, then centrifuged at 20,000 g for 15min
at 4°C. The supernatants from the two steps were
combined, and protein concentrations were de-
terminedwith the bicinchoninic acid protein assay
(Thermo Fisher Scientific). For the precipitation
and digestion of proteins in each sample, 200 mg
of protein was precipitated with six volumes of
ice-cooled acetone and kept 16 hours at –20°C.
Then proteins were resuspended in 8 M urea/
0.1 M NH4HCO3 buffer, reduced with 12 mM
dithiotreitol for 30 min at 37°C, then alkylated
with 40 mM iodoacetamide for 45 min at 25°C,
in the dark. Samples were diluted with 0.1-M
NH4HCO3 to a final concentration of 1.5-M urea,
and sequencing grade porcine trypsin (Promega)was
added to a final enzyme:substrate ratio of 1:100
and incubated for 16 hours at 37°C. Peptide
mixtures were cleaned by Sep-Pak tC18 cartridges
(Waters, Milford, MA, USA) and eluted with 40%
acetonitrile. The resulting peptide samples were
evaporated on a vacuum centrifuge until dry, then
resolubilized in 2% acetonitrile/0.1% formic acid
to 1mg/mL concentration.
For liver metabolites, the ~100-mg liver pieces
were homogenized in 1 mL of 70% ethanol at
–20°C. Metabolites were extracted by adding 7 mL
of 70% ethanol at 75°C for 2 min. Extracts were
centrifuged for 10 min at 4000 rpm at 4°C. Clean
metabolite extracts were dried in a vacuum cen-
trifuge and resuspended in double-distilled H2O,
with volume according to the weight of the ex-
tracted liver piece. Quantification of metabolites
was performed on an Agilent 6550 quadrupole
orthogonal acceleration–time-of-flight (Q-TOF) in-
strument by flow injection analysis time-of-flight
mass spectrometry (24). All samples were injected
in duplicates. Ions were annotated based on their
accurate mass and the Human Metabolome Data-
base reference list (44), allowing a tolerance of
0.001 Da. Unknown ions and those annotated as
adducts were discarded. Theoreticalm/z ratios—
beyond the significant digits from the measure-
ment sensitivity—are used as the unique index in
the data files and online on GeneNetwork. For
example, deprotonated fumarate corresponds
to 115.0036897_MZ, malate to 133.0142794_MZ,
a-ketoglutarate to 145.0141831_MZ, and D2HG
to 147.0298102_MZ.
For blood serum analysis, samples were frozen
in liquid nitrogen until large “batches”were ready,
which were run in multiples of 16 samples. Sam-
ples were then thawed on ice, diluted 1:1 in NaCl
solution, and then processed on a Dade Behring
DimensionXpandClinical Chemistry System. Six-
teenmetabolites were measured based on stan-
dard reagent-reaction spectrophotometry. Due
to the long period of time for this study, two
chemical batch effects were noted for HDL, free
fatty acids, aspartate transaminase, lactate dehy-
drogenase, and creatinine measurements. These
metabolite measurements separated distinctly
into two batches based on the time of measure-
ment and a change in the batch of reagent used.
To account for this, the two batches for these five
metabolites were Z-score normalized and then
combined, losing information about absolute val-
ues but retaining utility for correlation analyses.
BN-PAGE and in-gel activity
For SC analysis, mitochondria were isolated, pro-
tein was extracted, and these extracts were pre-
pared and run on BN-PAGE, described in detail
in a separatemethods paper (45). In brief, ~30mg
of tissue was homogenized and taken for mito-
chondrial isolation. For BN-PAGE, 50 or 35 mg of
mitochondria from liver and heart, respectively,
was solubilized in digitonin and sample buffer
(Invitrogen, BN 2008). For the liver, these samples
were the same tissues used for omics analysis,
using all CD cohorts with three biological repli-
cates per cohort. For the heart, these were the
same mice as for the liver. Digitonin/protein ratio
of 4 g/g was used for liver and 8 g/g was used for
heart (for better band resolution, because heart
contains more SCs than liver). Electrophoresis
was performed using Native PAGENovex Bis-Tris
Gel System (3 to 12%), as per manufacturer’s
instructionswithminormodification.Gel transfer
was performed using Invitrogen iBlot gel transfer
system. For detection of the complexes, anti-oxphos
cocktail (Invitrogen, 457999) andWesternBreeze
Chromogenic Western Blot Immunodetection Kit
(Invitogen, WB7103) were used. In the final detec-
tion step, incubation of the membrane with the
chromogenic substrate was for 8 min for all the
gels. Membranes were dried, scanned, and each
visible SC band was independently scored from
1 to 5. All samples were then run across several
gels, and we observed nearly complete biological
reproducibility (heritability) for band presence or
absence. Contrast across gels varied significantly;
thus, bands were categorized in a binary manner
as “present” or “not present” for QTL analysis.
For in-gel activity assays, electrophoresis was
performed for 3 hours (30 min at 150 V and
2.5 hours at 250 V). Complex I activity was per-
formed by incubating the gels for 15 to 30min in
the substrate composed of 2 mM tris-HCl pH 7.4;
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0.1mg/mLNADH, and 2.5mg/mLnitrotetrazolium
blue. CIV activity was performed by incubating
the gels for 30 to 40 min in the substrate com-
posed of 25 mg of 3,3′-diamidobenzidine tetra-
hydrochloride; 50 mg cytochrome c; 45 mL of
50mMphosphate buffer pH 7.4, and 5mLwater.
CIV+CI activity was performed by subsequently
incubating the gels in the substrate for CIV fol-
lowed by incubation in CI. All reactions were stop-
ped with 10% acetic acid.
BN-PAGEwas run as well for six cohorts in the
HFD state.We observed no clear difference across
diets, and no difference related to the COX7A2L-
dependent bands. In-gel activity assays were run
for CI, CIV, CIV+CI, andCIII for eight strains (four
with the B6 allele of Cox7a2l and four for the D2
allele).
Proteomics: Peptide library development
To develop peptide libraries, we chose 58 cohorts
and used 100 mg of protein lysate each (digested
as described above). The resulting peptides were
mixed and loaded for off-gel electrophoresis
fractionation as previously described (46). The
24 fractions were combined into 10 fractions and
cleaned up with C18 column. Each fraction was
analyzed with classical shotgun data acquisition
with a AB Sciex TripleTOF 5600 mass spectrom-
eter interfaced to an Eksigent NanoLC Ultra 2D
Plus high-performance liquid chromatography
system. Samples were loaded on to a PicoFrit emit-
ter coupledwith an analytical column (75mmdiam-
eter) with buffer A (2% acetonitrile, 0.1% formic
acid) and eluted with a 135-min linear gradient of
2 to35%bufferB (90%acetonitrile, 0.1% formic acid)
with a flow rate of 300 nL/min. The 20 most in-
tense precursors with charge states 2 to 5 were
selected for fragmentation, and the MS2 spectra
were acquired in the range 50 to 2000 m/z for
100ms, and precursor ions were excluded from
reselection for 15 s.
Profile mode wiff files from shotgun data ac-
quisition were transformed to centroid mode and
converted to mzML files using AB Sciex Data
Converter, and then converted tomzXMLfilesusing
FileConverter. The mzXML files were searched
against the canonical UniProt complete proteome
database for mouse using the Trans-Proteomic
Pipeline (47). A decoy database was generated by
reversing the amino acid sequences and appended
to the target database. Cysteine carboxy-amido-
methylation was set as the static modification,
andmethionine oxidation was set as the variable
modification. Peptides with up to one missed
cleavage site were allowed. Mass tolerance was
set to 25 parts per million for precursor ions and
0.4 Da for fragment ions. The pepXML files were
combined using iProphet (48), and the integrat-
ed pepXML file was used to generate the redun-
dant spectra library containing all peptide spectra
matches using SpectraST (49). Retention time of
peptide identificationwas transformed to indexed
retention time (iRT) values based on the linear
regression calibrated for each shotgun run using
the information of the spiked iRT peptides. The
median of iRT values of each peptide were calcu-
lated using in-house script, and the consensus li-
brary was constructed using SpectraST. We then
selected the top five most abundant b and y frag-
ment ions of each peptide to generate the assays
for SWATH-MS targeted extraction. The target
assay library contains the precursor and fragment
m/z values and the relative intensities of the
fragment ions, as well as the average iRT value
of each precursor. Decoy assays were appended
to the target assay library for error rate estimation.
Proteomics: SWATH mass spectrometry
and targeted data extraction
SWATH-MS represents the next generation in
large-scale quantitative proteomics measure-
ment techniques and provides a substantial leap
in both scope and quality over the most com-
monly used untargeted proteomics technique
today, discovery proteomics (also known as shot-
gun proteomics). Although discovery proteomics
achieves high proteome coverage, the identifica-
tion and quantification are biased toward those
proteins with higher abundance in the sample,
and it suffers from inherently poor reproduci-
bility when large sample cohorts are being ana-
lyzed. This hurdle has limited the implementation
of this approach in large population studies. Re-
cently, targeted proteomics methods have been
developed to increase the reproducibility of pro-
teome measurement, such as selected reaction
monitoring [used in our previous study (19)]. Due
to lower throughput, however, studies using these
alternative techniques inevitably measure fewer
proteins than studies using shotgun proteomics.
Recently, we have developed SWATH, which has
demonstrated the ability to quantify thousands
of proteins with good reproducibility and quan-
tification accuracy across large sample cohorts (3).
Consequently, SWATHprovides considerable im-
provements in both proteome coverage andmea-
surement reproducibility.
The SWATH-MSwas performedwith the 5600
TripleTOF mass spectrometer, as previously de-
scribed (3). The chromatographic parameters
were as described above. For SWATH-MS–based
experiments, themass spectrometer was operated
in a looped product ion mode and specifically
tuned to allow a quadrupole resolution of 25 Da/
mass selection. Using an isolation width of 26 Da
(containing 1 Da for the window overlap), a set of
32 overlapping windows was consecutively con-
structed covering the 400 to 1200m/z precursor
range (3). The collision energy (CE) for each win-
dow was determined based on appropriate colli-
sion energy for a charge 2+ ion centered upon the
window with a spread of 15 eV. An accumulation
time (dwell time) of 100 ms was used for all frag-
ment ion scans in high-sensitivity mode. The sur-
vey scans were acquired in high-resolution mode
at the beginning of each SWATH-MS cycle, result-
ing in a duty cycle of 3.4 s.
The SWATH-MS results were first converted
to profile mzXML files using ProteoWizard (50).
The SWATH-MS targeted data extraction was
performed using OpenSWATH workflow (51),
which applies a target-decoy scoring model to
estimate the false discovery rate (FDR) by the
mProphet algorithm (52). Retention time align-
ment between SWATH maps was performed
based on the clustering of reference peptides using
a nonlinear alignment algorithm (53). Fragment
ion chromatograms were extracted according to
the target-decoy assay library with a width of
0.05 m/z, and peak groups were scored based
on the elution profile of fragment ions, similarity
of elution time and relative intensities with the
assay library, and the properties of the tandemMS
spectrum extracted at the chromatographic peak
apex. Finally, peptide FDRwas estimated accord-
ing to the score distribution of target and decoy
assays.
Proteomics: SWATH protein
classification and quality control
A key in all protein measurement techniques,
including antibody-based approaches, is that they
must choose and quantify a specific, small subset
of the protein’s overall amino acid sequence to
analyze. ProteinProphet analysis on the data
from OpenSWATH ensures that the peptides
identified are proteotypic (54). Themajority of the
resulting quantified peptides—20,718 of 22,208—
are uniquely attributable to a single protein. The
remaining 1510 match common regions of up to
nine distinct proteins; these peptides were dis-
carded from analysis in this study. All 22,208
peptides are recorded and available in the raw
file download on GeneNetwork.org. Peptide quan-
tities were calculatedwith imsbInfer, an R package
(https://github.com/wolski/imsbInfer). We further-
more analyzed several peptide sequences known
to target amino acid sequences with missense
mutations in the BXD (e.g., the peptide SAVYPT-
SAVQMEAALR for the gene Mrsa has a M to L
variant at the highlighted amino acid). In this
case, we observed striking differences in the alleles
that were not observed for other peptides mea-
suring the same gene that do not have the mis-
sense mutation. Thus, 100% amino acid matches
are necessary for reliable detection, indicating
that our unique peptides were accurately assigned.
Thesemissensemutations can lead to false-positive
cis-pQTLs; thus, in cases where only one peptide
mapped to a cis-pQTL, we controlled for sequence
variants, often highlighting missense mutations.
After performing all of these controls, we were
typically left withmultiple peptidemeasurements
corresponding to a single protein (a bit over seven
peptides per protein on average, although this
number is highly variable). To reduce multiple
testing in subsequent multilayered analyses, we
thus assigned the “best” peptide to represent the
overall gene level. This was done through several
sequential criteria: (i) peptides mapping as cis-
pQTLs, (ii) peptides with at least nominally sig-
nificant correlation to transcript (P < 0.05), and
(iii) peptides correlating with known controls in
independent layers of data [e.g., HMGCS1 should
fluctuate with mevalonate (55) (Fig. 2E)]. A total
of 632 proteins were assigned based on criteria i,
and a further 824were assigned based on criteria
ii, whereas only a single protein was assigned
based on criteria iii. The remaining 1165 proteins
were assigned to peptides based on intensity—
a standard selection criterion inMS analyses (56).
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cis-pQTL andmRNA-peptide correlations were
performed at a per-peptide level. Due to the in-
creased multiple testing issue of taking all indi-
vidual peptides, network analyses were performed
with only one peptide per gene (i.e., per protein),
as were trans-pQTL analyses and all other tran-
somic analyses. It is worth noting that this obstacle
of multiple peptides per protein is analogous to
pioneering quantitative polymerase chain reaction
experiments and microarray design, where there
were also considerable difficulties and trial-and-
error methods for choosing the “correct” primers
(or probe sets or RNA-seq reads) that most cor-
rectly measure overall transcript levels (57). Al-
though nearly two decades of transcriptome
research has led to the fairly reliable establishment
of which RNA fragments correspond properly to
the overall transcript, no similar database is yet
available for proteins. However, as we generally
observe strong networks of associated genes (e.g.,
Fig. 4), we can determine that the peptides, by and
large, accurately represent the protein levels. In
time, with many studies such as this one, we ex-
pect that it will become feasible to determine
guidelines and databases for how to best deter-
mine overall protein level from individual peptides.
Cholesterol validation
Huh7 and HepG2 cells were grown in Dulbecco’s
minimum essential medium (DMEM) or MEM,
respectively, and supplemented with 10% fetal
bovine serum. Cells were treated for 48 hours
(drugs) or 72 hours (siRNA knockdown) before
harvesting and preparation of peptides for mass
spectrometric analysis. Control conditions for
drug experiments consist of untreated and 0.1%
dimethyl sulfoxide–treated cells; control condi-
tions for siRNA-knockdown experiments consist
of cells that were untreated, mock treated (only
lipofectamine RNAiMAX transfection reagent),
or cells treated with negative-control siRNA (anti-
sense strand: CUACGAUAGACCGGUCGUAtt). Si-
lencer Select siRNAswere used in a concentration
of 5 nM. Knockdown of proteins was performed
for LDLR (low-density lipoprotein receptor) with
siRNAs s224006 and s224007; for SREBF2 with
siRNA s27 and s28; for SREBF (sterol regulatory
element binding transcription factor) with a mix
of s27, s28, s129, and s130, targeting both SREBF1
and SREBF2. For the LPDS + statin condition,
cells were incubated in medium containing 10%
LPDS and 1 or 5 mM atorvastatin. Protein signal
was quantified for three peptides for MMAB and
ECHDC1 and five peptides for HMGCS1, and
signal was normalized to control conditions. Ex-
periments were performed for all conditions in
two or three biological replicates for siRNAor drug
experiments, respectively. The box plots consist,
therefore, of two (SREBF si), four (SREBF2 si,
LDLR si), or six (drug controls, siRNA controls,
and LPDS statin) data points.
Metabolomics in liver: Metabolite
classification and quality control
We identified 979 unique metabolite features
based on m/z using flow-injection TOF-MS. Of
these features, 699 could be attributed to a single
metabolite, including in cases where of the two
“possible” enantiomers, one is more predominant
than the other (e.g., L versus D amino acids). The
remaining 280 metabolites were “clusters” with
no clear predominant feature—for example, the
“glucose”metabolite measurements could not be
separated from fructose, galactose, or mannose
measurements, as all share the same m/z. The
“main” metabolite and all possible alternatives
are listed with the data on GeneNetwork.org for
the raw file download (press the “INFO” button
next to the data set on the main search page and
download the data set and supplemental data
files).
Normality and significance
Outliers were Windsorized for QTL mapping,
which was performed using R/qtl (58). The nor-
mality of data was checked by the Shapiro-Wilk
test in R, with W ≥ 0.90 considered normal.
Student’s t test was used for two-group compar-
isons in normal data, andWelch’s t test was used
otherwise. Bonferroni’s correction was used for
multiple testing for tests of correlation. FDR calcu-
lations were used for peptide scoring. cis-QTLs
used a LRS = 12 as the significance threshold,
whereas trans-QTLs used a LRS = 18, as cis-QTLs
do not need to correct for multiple locus testing
across the genome. Raw P values and corrected
P values are both reported when applied.
Figure preparation
Network graphs (Figs. 1I; 4, A, C, and G; and 5A)
were performed using Spearman correlation, keep-
ing all edges with P values less than or equal to
the reported cutoff in the panel legend. These
panels weremade in R using the custompackage
imsbInfer, currently on Github (https://github.com/
wolski/imsbInfer) but in the process of being added
to Bioconductor. The Circos plot (Fig. 5B) was
generated using Circos (http://www.circos.ca).
Spearman correlation matrices (Figs. 3B and
4F) were generated in R using the corrgram
package. Metabolite structures were drawn with
ChemBioDraw (Fig. 3G). QTL plots were drawn in
R/qtl (e.g., Fig. 3, A, D, and I). Most other figures
(e.g., Fig. 1, C to H and J) were generated using
standard R plotting packages included in gplots
or ggplot2—e.g., stripchart, plotCI, and barplot2.
Final figures were all prepared with Adobe Illus-
trator.Westernblots andBN-PAGEgelswere trans-
ferred and scanned, then cropped for the figure
preparation without other rearrangement or edit-
ing, except for Fig. 5F,where biological tripletswere
“cut” and rearranged based on numerical order of
the BXDs. For this panel, contrast was edited
individually to obtain an even tone across the full
complement of strains. Because this is across
several independent gels, the relative intensity
across strains is unreliable, hence the binary as-
signment of SC presence rather than quantity.
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